{"id":"W2273853937","doi":"10.1016/j.lungcan.2016.02.013","title":"ER2, a novel human anti-EGFR monoclonal antibody inhibit tumor activity in non-small cell lung cancer models","year":2016,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"ca_institutions":"Biotechnology Research Institute","funders":"","keywords":"Cetuximab; In vivo; Monoclonal antibody; A549 cell; Epidermal growth factor receptor; Chemistry; Cancer research; Apoptosis; Pharmacology; Receptor; Medicine; Biology; Antibody; Immunology; Biochemistry","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001112981,0.0003697995,0.0005547401,0.0002136228,0.0001534213,0.00003373976,0.0001470582,0.000128141,0.0004568286],"category_scores_gemma":[0.000007257589,0.0002642519,0.0001580681,0.0003356902,0.00008251202,0.0003548334,0.00007926124,0.0002501732,0.000009579949],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001625395,"about_ca_system_score_gemma":0.0008050925,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.009842866,"about_ca_topic_score_gemma":0.002640776,"domain_scores_codex":[0.9979622,0.00002652112,0.0003570636,0.000679492,0.000337507,0.0006372358],"domain_scores_gemma":[0.9989568,0.00005041808,0.0001915002,0.0004148223,0.0001503735,0.0002361135],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.0002328236,0.001058541,0.4450297,0.0005991514,0.0004528946,0.0001341611,0.001321283,0.001422579,0.5438523,0.000233038,0.002830837,0.002832686],"study_design_scores_gemma":[0.03270685,0.0004055232,0.7994503,0.005872838,0.002373816,0.000042852,0.000164536,0.0290117,0.1250998,0.0002528583,0.002955091,0.001663916],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9858063,0.002137447,0.002808721,0.001646191,0.0004423253,0.001289388,0.0003657981,0.00008326343,0.005420579],"genre_scores_gemma":[0.991749,0.0004423235,0.0004025897,0.000597469,0.000418374,0.0007034887,0.00003100806,0.00007974661,0.005576032],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4187525,"threshold_uncertainty_score":0.999981,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0188192176814274,"score_gpt":0.3506939886329891,"score_spread":0.3318747709515616,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}